Overview
The Linx Reflux Management System, a magnetic ring implanted around the esophagus to treat gastroesophageal reflux disease (GERD), has faced significant safety concerns prompting Johnson & Johnson to halt sales outside the U.S. in September 2025. Designed to prevent acid reflux by mimicking the lower esophageal sphincter’s function, the device was approved by the FDA in 2012 and marketed as a minimally invasive alternative to traditional surgery.
However, reports of device migration, erosion, and failure have led to recalls and lawsuits, with patients experiencing severe complications like esophageal tears and the need for emergency revision procedures. The U.S. Food and Drug Administration (FDA) has documented over 1,000 adverse events since 2012, including 100 deaths and 1,200 serious injuries, fueling claims that Johnson & Johnson downplayed risks in its FDA submissions and marketing materials.
Class action litigation is gaining momentum, with plaintiffs seeking damages for negligence, product liability, and failure to warn, as the company faces pressure to address the device’s long-term safety profile [1][2][3][4].
Johnson & Johnson’s withdrawal, announced on September 23, 2025, affects markets in Europe, Asia, and Latin America, where the device was sold for $15,000–$20,000 per procedure. In the U.S., the Linx remains available but under increased scrutiny, with the FDA issuing a Class I recall for certain lots in 2024 due to manufacturing defects.
This move follows a pattern of global regulatory actions, including European Union warnings in 2023 about migration risks. Lawsuits allege that the company’s failure to disclose the full extent of complications, including a 10–15% revision surgery rate, misled patients and surgeons, resulting in unnecessary procedures and lifelong health issues.
Affected Linx Implant Models
The class action lawsuits and recalls primarily target the Linx Reflux Management System models, identifiable by their serial numbers and implantation dates:
- Linx Reflux Management System (Model LS-10, LS-11): Implanted from 2012 to 2023, these titanium-encased magnetic beads were used in over 50,000 procedures worldwide. Recalled lots include those with serial numbers beginning with “AB” for manufacturing defects causing bead separation [4].
- Linx HiRes Ultra and Ultra 3D: Advanced models implanted from 2018 to 2025, linked to higher migration rates (up to 20% in some studies), prompting the international withdrawal [1][2].
Patients can verify affected devices by contacting their surgeon or checking FDA recall databases using the device serial number, typically found in medical records or on the implant card provided post-surgery [4].
Hazards of the Defective Linx Implants
The Linx device’s primary hazards include:
- Device migration, where the magnetic ring shifts from its esophageal position, causing pain or obstruction.
- Erosion into surrounding tissues, leading to esophageal tears or fistulas.
- Bead separation or corrosion, resulting in foreign body reactions and inflammation.
- Failure to control reflux, necessitating revision surgery with risks of infection or anesthesia complications.
- Long-term dysphagia or chest pain from improper bead function.
These issues have led to over 1,000 adverse events, including 100 deaths, often from perforation or sepsis following migration [1][2][4].
Symptoms of Linx Implant Complications
Patients experiencing device failure may report:
- Difficulty swallowing (dysphagia) or food regurgitation
- Severe chest pain or abdominal discomfort
- Vomiting blood or black stools indicating esophageal bleeding
- Shortness of breath or fever from infection
- Weight loss or malnutrition from eating difficulties
These symptoms often require urgent endoscopy or surgery to diagnose and treat migration or erosion [3][4].
Recall Remedy and Consumer Actions
Johnson & Johnson has recalled specific Linx lots in the U.S. and withdrawn the device globally outside the U.S., advising surgeons to stop implanting new units. Affected patients should contact their surgeon for evaluation and potential revision surgery, covered under warranty if within 5 years. The FDA recommends monitoring for symptoms and reporting adverse events via MedWatch. No direct consumer remedy exists for implanted devices, but class actions seek to establish funds for revisions. Patients can document symptoms and medical records for potential claims [1][2][4].
Potential for a Class Action Lawsuit
With over 50,000 Linx implants worldwide and 1,000+ adverse events, class action lawsuits are gaining traction, particularly in the U.S. and Canada. The Bolger v. Johnson & Johnson case, filed in 2023, alleges the company concealed migration risks (10–15% rate) and misled the FDA about safety data, violating consumer protection laws.
Claims include product liability, fraud, and failure to warn, seeking damages for medical costs (revision surgeries ~$20,000–$30,000), pain, and punitive awards. In Canada, a class action launched by Gluckstein Lawyers in 2024 represents patients with failed HiRes models, estimating thousands of eligible claimants.
These suits argue Johnson & Johnson prioritized profits over safety, with internal documents revealing awareness of defects since 2015. Successful litigation could lead to a multidistrict settlement fund for revisions and compensation, similar to other medical device cases like the $4.85 billion in Ethicon mesh lawsuits [1][2][3][4].
Do I Have a Linx Acid Reflux Implant Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Linx acid reflux implant lawsuits. We are handling individual litigation nationwide and currently accepting new revision surgery or device failure cases in all 50 states.
Free Linx Acid Reflux Implant Class Action Lawsuit Evaluation: If you or a loved one experienced device migration, erosion, or required revision surgery from a Linx Reflux Management System, you should contact our law firm immediately. You may be entitled to compensation by filing a Linx acid reflux implant class action suit and our lawyers can help.
References
- 1. https://www.bloomberg.com/news/articles/2025-09-23/j-j-to-withdraw-acid-reflux-device-outside-us-alarming-surgeons
- 2. https://www.aboutlawsuits.com/linx-reflux-lawsuit/linx-acid-reflux-device-recalled-foreign-markets/
- 3. https://www.aboutlawsuits.com/linx-implant-lawsuit-over-device-failure-led-to-revision-surgery/
- 4. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=163595